Get 20% lifetime commission for referring investors to digrin.com
here.
Eledon Pharmaceuticals, Inc. ( ELDN) - Stock Earnings
ELDN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
ELDN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -10.4 million USD | — USD |
| 2026Q1 | -39.0 million USD | — USD |
| 2026Q2 | -31.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ELDN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -40.3 million USD | — USD |
| 2024 | -36.2 million USD | — USD |
| 2025 | -45.6 million USD | — USD |
| 2026 Est. | — | — |
ELDN
Price: $3.62
52 week price:
Earnings Per Share: -0.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 24400
Market Capitalization: 287.7 million